Skip to main content
    H

    Harmony Biosciences Holdings (HRMY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $32.96
    -0.80 (-2.37%)

    Market Cap: $1.98B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Harmony Biosciences Holdings (HRMY) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Harmony Biosciences Holdings (HRMY) trades at 9.6x trailing earnings and 1.9x sales. Its P/E of 9.6x is below its 5-year median of 10.9x. Its forward P/E is 8.4x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 14.3% higher over the next year.

    MultipleValue
    P/E (trailing)9.6x
    Forward P/E8.4x
    Price to sales1.9x
    Price to book1.8x
    EV/EBITDA5.9x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/E9.6x10.9xN/A
    P/S1.9x3.1xN/A
    P/B1.8x3.6xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 5 of the 6 year ends shown that have a P/E, its P/E ranged from 8.5x in 2024 to 51.4x in 2021.

    Year endPriceP/EP/SP/B
    2025$37.4211.2x2.5x2.5x
    2024$34.418.5x2.8x3.0x
    2023$32.3011.4x3.3x4.1x
    2022$55.1019.5x7.5x8.4x
    2021$42.6451.4x8.1x13.8x
    2020$36.15N/A10.4x21.2x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HRMY

    What is HRMY's forward P/E ratio?

    Harmony Biosciences Holdings has a forward P/E ratio of 8.4x.

    Is HRMY stock overvalued?

    GNG's valuation label for HRMY is Undervalued.

    What is HRMY's price to sales ratio?

    Harmony Biosciences Holdings has a price to sales ratio of 1.9x.

    What is Harmony Biosciences Holdings's average P/E ratio over 5 years?

    Harmony Biosciences Holdings's median P/E over the last 5 years is 10.9x, from 60 month-end values through Oct 2026.